
Experts say this could prompt firms to seek a stay on anti-profiteering proceedings till the time the issue surrounding constitutional validity is settled by high courts.
from Healthcare/Biotech-Industry-Economic Times http://bit.ly/2VfcSmI
via
IFTTT
0 comments:
Post a Comment